AU2003249999A1 - 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours - Google Patents

1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours

Info

Publication number
AU2003249999A1
AU2003249999A1 AU2003249999A AU2003249999A AU2003249999A1 AU 2003249999 A1 AU2003249999 A1 AU 2003249999A1 AU 2003249999 A AU2003249999 A AU 2003249999A AU 2003249999 A AU2003249999 A AU 2003249999A AU 2003249999 A1 AU2003249999 A1 AU 2003249999A1
Authority
AU
Australia
Prior art keywords
tetraazacyclododecanes
guanine
modulators
binding protein
treating tumours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003249999A
Other versions
AU2003249999A8 (en
Inventor
Hans Robert Kalbitzer
Burkhard Konig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10239612A external-priority patent/DE10239612A1/en
Application filed by Individual filed Critical Individual
Publication of AU2003249999A1 publication Critical patent/AU2003249999A1/en
Publication of AU2003249999A8 publication Critical patent/AU2003249999A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
AU2003249999A 2002-07-10 2003-07-09 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours Abandoned AU2003249999A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10231270.2 2002-07-10
DE10231270 2002-07-10
DE10239612.4 2002-08-29
DE10239612A DE10239612A1 (en) 2002-07-10 2002-08-29 Methods and connections for influencing the spatial structure of GNB proteins
PCT/EP2003/007367 WO2004006934A2 (en) 2002-07-10 2003-07-09 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours

Publications (2)

Publication Number Publication Date
AU2003249999A1 true AU2003249999A1 (en) 2004-02-02
AU2003249999A8 AU2003249999A8 (en) 2004-02-02

Family

ID=30116624

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003249999A Abandoned AU2003249999A1 (en) 2002-07-10 2003-07-09 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours

Country Status (2)

Country Link
AU (1) AU2003249999A1 (en)
WO (1) WO2004006934A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010114308A1 (en) * 2009-04-03 2010-10-07 Snu R&Db Foundation Heterocycle-amino acid derivatives for targeting cancer tissue and radioactive or non-radioactive labeled compounds thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2671575A1 (en) 2012-06-04 2013-12-11 Universität Regensburg Ras inhibitors
WO2014153624A1 (en) * 2013-03-28 2014-10-02 The University Of Sydney Antibacterial compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3640708C2 (en) * 1986-11-28 1995-05-18 Schering Ag Improved pharmaceuticals containing metals
DE4009119A1 (en) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-TETRAAZACYCLODODECANE-BUTYLTRIOLS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
US5272056A (en) * 1991-01-03 1993-12-21 The Research Foundation Of State University Of New York Modification of DNA and oligonucleotides using metal complexes of polyaza ligands
DE19603033A1 (en) * 1996-01-19 1997-07-24 Schering Ag Perfluoroalkyl-containing metal complexes, processes for their preparation and their use in NMR diagnostics
DE19608278A1 (en) * 1996-02-23 1997-08-28 Schering Ag Pharmaceutical compositions containing perfluoroalkyl-containing metal complexes, and their use in tumor therapy and interventional radiology
DE19641197C2 (en) * 1996-09-24 1999-02-18 Schering Ag Ion pairs and their use as contrast agents
DE19719033C1 (en) * 1997-04-29 1999-01-28 Schering Ag Ion pairs, processes for their preparation and their use as contrast agents
AU6074599A (en) * 1998-10-13 2000-05-01 Synchem Reserach, Inc. Biomimetic chelating agents and methods
DE19849465A1 (en) * 1998-10-21 2000-04-27 Schering Ag New dimeric ion pairs containing cationic and anionic metal complexes; useful as low viscosity contrast agents for X-ray, magnetic resonance and radiodiagnostic techniques, and as radiotherapy agents
JP2003516984A (en) * 1999-12-17 2003-05-20 アノーメッド・インコーポレイテッド Heterocyclic compounds that bind chemokine receptors
AU2001244609A1 (en) * 2000-03-30 2001-10-15 Takeda Chemical Industries Ltd. Novel protein, dna thereof and process for producing the same
AU2001286644A1 (en) * 2000-08-25 2002-03-13 Genaissance Pharmaceuticals, Inc. Haplotypes of the gng7 gene
DE10104389A1 (en) * 2001-01-19 2002-08-01 Schering Ag New multimeric photosensitizer, useful in photodynamic therapy of cancers and other angiogenic conditions, can also be conjugated with e.g. protein, antibody or oligonucleotide

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010114308A1 (en) * 2009-04-03 2010-10-07 Snu R&Db Foundation Heterocycle-amino acid derivatives for targeting cancer tissue and radioactive or non-radioactive labeled compounds thereof

Also Published As

Publication number Publication date
WO2004006934A2 (en) 2004-01-22
WO2004006934A3 (en) 2004-04-01
AU2003249999A8 (en) 2004-02-02

Similar Documents

Publication Publication Date Title
AU2003299791A1 (en) Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
AU2003281978A1 (en) 2,5-diketopiperazines for the treatment of obesity
AU2003218767A1 (en) Fabric treatment composition
AU2003297318A1 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476.
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
AU2002225930A1 (en) Methods for treating phosphatide-containing mixtures
AU2002368133A1 (en) 1,3-azole derivative and medicinal composition containing the derivative for treatment for thombosis
AU2003903242A0 (en) Process for the treatment of wood
EP1551388A4 (en) Compounds useful for the treatment of cancer, compositions thereof and methods therewith
AU2003223538A1 (en) Methods for the treatment of cancer
AU2002335667A1 (en) Modified reoviral therapy
AU2003220026A1 (en) Methods and compositions for the treatment of ischemia
AU2003249999A1 (en) 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours
AU2003232108A1 (en) 1,1- and 1,2-bisphosphonates as apoliprotein e modulators
AU2003296545A1 (en) Use of a trpm8-activating substance for the treatment of tumours
AU2003224486A1 (en) Composition for treating cancer containing n,n-dimethylphytosphingosine
AU2002304883A1 (en) Device for the treatment of tumours
AU2003266960A1 (en) Composition for the treatment of pain, especially for the treatment of articular pain
AU2002365621A1 (en) Composition for treating the surface of the skin
AU2003235236A1 (en) Lyophilization product
AU2003225258A1 (en) Fiber treatment composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase